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Background. The relationship between mental and physical disorders is well established, but there is less consensus
as to the nature of their joint association with disability, in part because additive and interactive models of co-morbidity
have not always been clearly differentiated in prior research.
Method. Eighteen general population surveys were carried out among adults as part of the World Mental Health
(WMH) Survey Initiative (n=42 697). DSM-IV disorders were assessed using face-to-face interviews with the Composite
International Diagnostic Interview (CIDI 3.0). Chronic physical conditions (arthritis, heart disease, respiratory disease,
chronic back/neck pain, chronic headache, and diabetes) were ascertained using a standard checklist. Severe disability
was defined as on or above the 90th percentile of the WMH version of the World Health Organization Disability
Assessment Schedule (WHODAS-II).
Results. The odds of severe disability among those with both mental disorder and each of the physical conditions
(with the exception of heart disease) were significantly greater than the sum of the odds of the single conditions. The
evidence for synergy was model dependent : it was observed in the additive interaction models but not in models
assessing multiplicative interactions. Mental disorders were more likely to be associated with severe disability than
were the chronic physical conditions.
Conclusions. This first cross-national study of the joint effect of mental and physical conditions on the probability
of severe disability finds that co-morbidity exerts modest synergistic effects. Clinicians need to accord both mental
and physical conditions equal priority, in order for co-morbidity to be adequately managed and disability reduced.
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Introduction
Disability, encompassing impairments, activity limi-
tations and/or participation restrictions (WHO, 2001),
is an important consequence of both physical and
mental disorders. Those studies that have assessed the
relative level of disability associated with physical and
mental conditions have found mental disorders to be
at least as disabling as common chronic physical con-
ditions (Wells et al. 1989b ; Hays et al. 1995 ; Armenian
et al. 1998 ; Ormel et al. 1998; Moussavi et al. 2007;
Ormel et al. in press). However, mental and physical
disorders are known to co-occur at greater than chance
levels (Wells et al. 1989a ; Dew, 1998; Buist-Bouwman
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et al. 2005 ; Scott et al. 2006b, 2007). This begs the ques-
tion as to the nature of their joint impact on disability.
A useful distinction has been drawn by Schettini
Evans & Frank (2004) between additive and interactive
models of co-morbidity. An additive model suggests
that the individual components of co-morbid disorders
have independent effects on functioning, which occur
together in linear combination (that is, the combined
effect is approximately equal to the sum of the parts).
An interactive model suggests that co-morbidity is
associated with significantly greater (or lower) levels
of dysfunction than predicted by a simple sum of the
disabling effects of the individual disorders. The im-
plication of the interactive model is that the presence
of one disorder alters the association of the other dis-
order with disability.
The investigation of this topic has not been exten-
sive thus far and has produced divergent results.
Some studies have researched the joint effects of
mental and physical disorder on disability and found
them to be greater than the effects of either condition
alone but have not been conclusive about whether
the nature of the joint effect is additive or synergistic
(Druss et al. 2000 ; Sareen et al. 2006 ; Moussavi et al.
2007). Other research that has distinguished between
additive and synergistic models has concluded that
mental and physical conditions have mostly additive
effects on disability (Wells et al. 1989b ; Ormel et al.
1998 ; Buist-Bouwman et al. 2005), although a few
studies have found synergistic effects (Kessler et al.
2001, 2003 ; Egede, 2004 ; Schmitz et al. 2007). By con-
trast, Merikangas et al. (2007) recently observed a
number of significant interactions between mental and
physical conditions in predicting days out of role that
were nearly all negative.
A contributor to the divergent findings is the fact
that researchers have used either linear regression
(which uses an additive scale) or logistic regression
(which uses a multiplicative scale) to assess interaction
effects. The underlying model of how mental and
physical disorders might combine is an additive one
(Ahlbom & Alfredsson, 2005), and the interaction of
risk factors should therefore be assessed as a depar-
ture from additivity not multiplicativity (Ahlbom &
Alfredsson, 2005; Andersson et al. 2005). The use of
logistic regression is more likely to result in no inter-
actions or negative interactions relative to using linear
regression, unless the logistic regression is adapted
to produce output needed for assessment of the inter-
action on an additive scale (Ahlbom & Alfredsson,
2005 ; Andersson et al. 2005 ; Schmitz et al. 2007).
The World Mental Health (WHM) Survey Initiative
(Kessler & Ustun, 2004) is a consortium of general
population surveys carried out in developing and
developed countries. The surveys used standardized
diagnostic assessment of mental disorders and also
collected information on chronic physical disease
prevalence and functional disability. This provides the
opportunity to address this research question on a
cross-national basis. In this paper we compare four
groups in terms of their association with disability :
those with mental disorder in the absence of a given
physical disorder, those with the physical disorder in
the absence of mental disorder, those with both, and
those with neither. Six common physical conditions
were investigated : arthritis, heart disease, respiratory
disease, chronic back and neck pain, chronic headache,
and diabetes. The mental disorders investigated in-
cluded those in the depressive-anxiety spectrum. The
objective was to ascertain whether the joint effect of
mental and physical conditions on the probability
of severe disability is significantly greater than, or
approximately equal to, the sum of the individual
effects.
Method
Samples
Eighteen surveys were carried out in 17 countries in
the Americas (Colombia, Mexico, the USA), Europe
(Belgium, France, Germany, Italy, The Netherlands,
Spain, Ukraine), the Middle East (Israel, Lebanon),
Africa (Nigeria, South Africa), Asia (Japan, separate
surveys in Beijing and Shanghai in the People’s
Republic of China) and the South Pacific (New
Zealand). All surveys were based on multi-stage,
clustered, area probability household samples. All
interviews were carried out face-to-face by trained
lay interviewers. Sample sizes range from 2372 (The
Netherlands) to 12992 (New Zealand) with a total of
85 088 respondents. Response rates range from 45.9%
(France) to 87.7% (Colombia), with a weighted aver-
age response rate of 70.8%.
Internal subsampling was used to reduce respon-
dent burden by dividing the interview into two parts.
Part 1 included the core diagnostic assessment of
mental disorders. Part 2 included additional infor-
mation relevant to a wide range of survey aims, in-
cluding assessment of chronic physical conditions. All
respondents completed Part 1. All Part 1 respondents
who met criteria for any mental disorder and a prob-
ability sample of other respondents also completed
Part 2. Part 2 respondents were weighted by the
inverse of their probability of selection for Part 2 of
the interview to adjust for differential sampling.
Analyses in this article were based on the weighted
Part 2 subsample (n=42 697). Additional weights
were used to adjust for differential probabilities of
selection within households, adjust for non-response
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and to match the samples to population socio-
demographic distributions.
Training and field procedures
The central WMH staff trained bilingual supervisors
in each country. The World Health Organization
(WHO) translation protocol was used to translate in-
struments and training materials. Some surveys were
carried out in bilingual (Belgium) or multilingual
form (Ukraine, Israel, Nigeria). Other surveys were
carried out exclusively in the country’s official
language. Persons who could not speak these
languages were excluded. Quality control protocols,
described in more detail elsewhere (Kessler et al. 2004),
were standardized across countries to check on inter-
viewer accuracy and to specify data cleaning and
coding procedures. The institutional review board of
the organization that coordinated the survey in each
country approved and monitored compliance with
procedures for obtaining informed consent and pro-
tecting human subjects.
Mental disorder status
All surveys used the WMH Survey version of the
WHO Composite International Diagnostic Interview
(WMH-CIDI, now CIDI 3.0 ; Kessler & Ustun, 2004),
a fully structured diagnostic interview, to assess dis-
orders and treatment. Disorders were assessed using
the definitions and criteria of DSM-IV (APA, 1994).
CIDI organic exclusion rules were imposed (the diag-
nosis was not made if the respondent indicated that
their episodes of depressive symptoms were always
due to physical illness or injury or use of medication,
drugs or alcohol). This paper includes 12-month
anxiety disorders (generalized anxiety disorder, panic
disorder and/or agoraphobia, post-traumatic stress
disorder, and social phobia) and depressive disorders
(dysthymia and major depressive disorder). Anxiety
and depressive disorders were aggregated into a
single category, on the basis of prior findings from the
WMH surveys that anxiety disorders and depressive
disorders have equal and independent relationships
with a wide range of chronic physical conditions
(Scott et al. 2007). This approach keeps manageable
the number of analyses that need to be carried out to
answer the research question in a cross-national
framework.
Chronic physical conditions
Physical conditions were assessed with a standard
chronic disorder checklist (NCHS, 1994). Prior research
has demonstrated reasonable correspondence between
self-reported chronic conditions such as diabetes,
heart disease and asthma, and general practitioner
records (Kriegsman et al. 1996).
For the chronic pain conditions reported here (back
or neck pain, headaches), respondents were asked if
they had ever had chronic back or neck problems
or frequent or severe headaches, and additionally,
whether they had experienced these symptoms in
the past 12 months (for Nigeria, Lebanon, China and
Ukraine respondents were only asked if they had
experienced these pain problems in the past 12
months). For the other conditions, respondents were
asked if they had ever been told by a doctor that they
had heart disease, asthma or other respiratory disease,
or diabetes. The question about arthritis was asked in
two different ways, depending on country. In Nigeria,
Lebanon, China and Ukraine, respondents were asked
if they had experienced arthritis or rheumatism in
the past 12 months. The remaining surveys asked
about arthritis in the same format as for heart disease,
respiratory disease and diabetes. For those conditions
where both lifetime or 12-month prevalences were
available (the chronic pain conditions), the 12-month
prevalence was used in these analyses on the assump-
tion that it would be more closely associated with the
current disability measure.
Disability
This was assessedwith theWMHSurvey version of the
WHO Disability Assessment Schedule (WHODAS-II),
referred to here as the WMH WHODAS. This instru-
ment assesses disability in several domains : role im-
pairment, mobility, self-care, social functioning and
cognitive functioning. It was administered as a generic
section to all participants in the Part 2 subsample,
asking about disability in the past 30 days attributable
to health, emotional or mental health problems. More
detail on the WMH WHODAS is provided elsewhere
(Scott et al. 2006a ; Von Korff et al. in press). As well
as domain scores, a global score can be calculated as
an aggregation of domain scores ; the global score is
used in this paper, given the large number of surveys
included. The global score does to some extent obscure
domain-specific differences in the disability associated
with mental and physical conditions ; these can be
observed in a separate report on the New Zealand
survey (Scott et al. 2006a).
Higher global scores (on a 0–100 scale) indicate
greater disability. Disability was dichotomized for the
current analyses ; it was calculated on a country-
specific basis and defined as a score on or above the
90th percentile of the WMH WHODAS distribution
in each country (i.e. capturing the most disabled 10%
of the population). We dichotomized the WMH
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WHODAS scores because their skewed distribution
meant that a mean score was not a good characteriz-
ation of central tendency in the general population.
The decision to use the 90th percentile as the cut-point,
rather than some other percentile, was somewhat
arbitrary, but was based on looking at the distributions
of each of the surveys, and consideration of the
percentage of the samples with significant disability
(which we took to indicate more clinically relevant
impairment). The 95th percentile appeared to be too
high a threshold and the 85th percentile too low.
Statistical analysis
The prevalence of a WMH WHODAS score on or
above the 90th percentile was calculated for those
with a given physical condition (in the absence of
mental disorder), for those with mental disorder (in
the absence of the physical condition), for those with
both mental disorder and the physical condition, and
for those with neither, on a country-by-country basis.
These prevalence estimates do not control for age and
sex differences across the disorder groups.
Because the tests for additive interactions were to
be run on the combined data set, we first ran a check
on whether pooling the data would obscure significant
variability between countries. Separate logistic re-
gression models were run for each physical condition,
for each country, estimating the age- and sex-adjusted
odds of severe disability among those with mental
disorder (in the absence of a given physical disorder)
and the given physical disorder (in the absence of
mental disorder). We assessed whether the hetero-
geneity of the odds ratio estimates across surveys
was greater than expected by chance (DerSimonian &
Laird, 1986), using an a of p<0.01. None of the tests
were found to be significant (data available on re-
quest).
To assess the interaction between mental disorder
and a given physical condition on an additive scale
but using logistic regression modelling (Andersson
et al. 2005), the two risk factors (mental disorder and
a given physical condition) were coded into three
dummy variables : (i) those with mental disorder in
the absence of the physical condition (MD), (ii) those
with a given physical condition in the absence of
mental disorder (PC), and (iii) those with both mental
disorder and the physical condition (MD+PC). The
group with neither mental disorder nor the physical
condition was the common reference category. These
dummy variables were entered simultaneously into
logistic regression models predicting the odds of a
WMH WHODAS score on or above the 90th percen-
tile, controlling for age, sex and education (with the
exception that France did not collect information on
education). A separate model was run for each of
the six physical conditions. We assessed whether
the odds of disability for the MD+PC group were
significantly greater than the sum of the odds for MD
and PC by calculation of a ‘synergy index’ (SI) :
SI=[ORMD+PCx1]=[(ORMDx1)+(ORPCx1)]:
If there is no synergistic effect, SI=1, and a value
significantly greater than 1 indicates a positive syner-
gistic effect (Andersson et al. 2005).
A series of conventional logistic regression models
were also run testing for interactions between mental
disorder and each physical condition on a multipli-
cative scale.
For countries in which the cross-classification of
mental disorder and the physical condition had a null
cell, the odds ratio was not calculated. Ninety-five
per cent confidence intervals for the odds ratios
were estimated using the Taylor Series Linearization
(Wolter, 1985) with SUDAAN software (SUDAAN,
2002) to adjust for clustering and weighting.
Results
Sample characteristics
The combined sample of those who completed the
longer version of the interview (Part 1+Part 2) in-
cluding the physical condition checklist was 42 697.
The Part 2 sample in each country ranged in size from
the smaller Asian surveys in Japan (887), Beijing (914)
and Shanghai (714), to the larger samples in New
Zealand (7312), the USA (5692), Israel (4859) and South
Africa (4315). The proportion of the sample that
was age 60 or greater was higher in the developed
countries than the developing countries, and the per-
centage with 12 or more years of education was also
generally higher in the developed countries. Further
detail on sample characteristics is provided elsewhere
(Scott et al. 2007).
Disability prevalence by disorder
The prevalence of a disability score in the top 10% of
the WMH WHODAS distribution was calculated for
mental disorder and each of the physical condition
groups, but by way of illustration only the results for
back or neck pain and for heart disease are shown
(Figs 1 and 2). These are reasonably indicative of the
results obtained for the other four physical conditions
(available on request). Generally speaking, those
without either the physical or the mental condition
were least likely to be represented among the most
disabled 10%, whereas those with both mental
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disorder and the physical condition were most likely
to be among the most disabled. It is important to note
that these descriptive results are not adjusted for age
and sex, which makes the distinctions between the
four groups in terms of their disability status less
clear-cut. It is also clear that there is a good deal of
variability across countries. Although there are likely
to be some substantive reasons for this, it is also partly
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Fig. 1. Percentage with a score in the top 10% of the WMHWHODAS distribution by mental disorder (––), chronic back or
neck pain (–&–), both () or neither (–2–) (not adjusted for age or sex).
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Fig. 2. Percentage with a score in the top 10% of WMHWHODAS distribution by mental disorder (––), heart disease (–&–),
both () or neither (–2–) (not adjusted for age or sex).
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a function of the fact that some of the surveys had
low prevalences of mental disorders, and so of the
co-morbidities, leading to potentially unstable esti-
mates. For this reason the estimates based on the
pooled dataset are likely to be the more reliable.
Pooled estimates
The results of the additive interaction models are
shown in Table 1. The odds of severe disability in the
three groups (MD, PC andMD+PC), plus the synergy
index, are displayed for the six physical conditions.
Three observations can be made. First, a comparison
of first two columns of data indicates that the odds
of severe disability were generally greater for mental
disorder (in the absence of a given physical condition)
than they were for any of the physical conditions
(in the absence of mental disorder). Second, the odds
of disability were always greater for those with both
mental disorder and the physical condition, relative
to either condition alone. Third, for all conditions ex-
cept heart disease, there was a significant synergistic
effect ; that is, the odds of severe disability were
significantly greater than the sum of the odds for the
single conditions (equivalent to a positive interaction
on an additive scale).
When the interaction of mental disorder with the
physical condition on disability was assessed within
multiplicative models, no evidence of positive syner-
gistic effects was found (data not shown; available
on request). In sum, we observed combined effects of
mental and physical conditions on disability that were
greater than additive, but less than multiplicative.
Discussion
This first global investigation of the relationship be-
tween depressive/anxiety disorders and six chronic
physical conditions with severe disability produced
three key findings. First, those with mental disorders
are more likely to be severely disabled than those with
the physical conditions investigated here. Second,
those with co-morbid mental and physical conditions
are more likely to be severely disabled than those with
either condition alone. Third, mental–physical co-
morbidity exerts a small degree of synergistic effect,
with the odds of severe disability among those with
both mental disorder and a physical condition being
significantly (albeit modestly) greater than the sum of
the odds of the single conditions, with the exception
of mental disorder–heart disease co-morbidity.
The finding of a synergistic effect of mental and
physical co-morbidity adds to other evidence of this
phenomenon (Kessler et al. 2001, 2003; Egede, 2004;
Schmitz et al. 2007), although, as noted above, at least
as many studies have found only additive effects.
There are many methodological differences across
studies that may account for the discrepancy between
additive and synergistic findings, but one we noted
earlier is that studies using logistic regression, when
this is adapted to assess interactions additively
(e.g. Egede, 2004 ; Schmitz et al. 2007 ; and the current
study), are more likely to observe synergistic effects
than when interactions are tested using multiplicative
models (e.g. Stein et al. 2006). This can be observed
directly in the current study in that the evidence for
synergy was model dependent : it was observed in the
Table 1. Odds of WMH WHODAS disability scoreo90th percentile, adjusted for age, sex and education, pooled data (n=42 697)
Physical condition
Physical
condition (PC)a
Mental
disorder (MD)b
Mental disorder+physical
condition (MD+PC) Synergy index (SI)c
OR (95% CI)d OR (95% CI)d OR (95% CI)d SI (95% CI)
Diabetes 1.8 (1.5–2.1)* 3.8 (3.5–4.2)* 8.8 (6.9–11.1)* 2.2 (1.6–2.9)*
Respiratory disease 2.0 (1.7–2.3)* 3.9 (3.6–4.3)* 6.1 (5.0–7.4)* 1.3 (1.0–1.7)*
Headache 2.4 (2.1–2.7)* 3.8 (3.5–4.2)* 6.6 (5.8–7.6)* 1.3 (1.1–1.6)*
Heart disease 2.7 (2.3–3.2)* 4.0 (3.7–4.3)* 6.9 (5.7–8.4)* 1.2 (1.0–1.6)
Arthritis 2.5 (2.2–2.8)* 4.0 (3.5–4.4)* 8.1 (7.0–9.3)* 1.6 (1.3–1.9)*
Back or neck pain 3.4 (3.0–3.8)* 4.0 (3.6–4.5)* 9.2 (8.1–10.4)* 1.5 (1.3–1.8)*
WMHWHODAS, World Mental Health version of the World Health Organization Disability Assessment Schedule ; OR,
odds ratio ; CI, confidence interval.
a PC=the specified physical condition in the absence of mental disorder.
bMD=either a 12-month depressive or 12-month anxiety disorder, or both, in the absence of the specified physical condition.
c SI=[ORMD+PC – 1]/[(ORMD – 1)+(ORPC – 1)]. If there is no synergistic effect, SI=1, and a value significantly greater
than 1 indicates a positive synergistic effect.
d Common reference group: those with neither mental disorder nor the specified physical condition.
* p<0.05.
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additive interaction models but not in models asses-
sing multiplicative interactions.
The particular contribution the current study
makes is that it is the first study sampling from both
developing and developed countries to specifically
investigate the nature of the joint effect of mental and
physical conditions on disability. Additionally, this
study used a measure of severe disability, rather than
any disability days (which can be influenced by brief,
inconsequential illness), encompassed the full adult
age range and used diagnoses of depression and
anxiety disorders based on the full CIDI, rather than
a short form or a scale measure of depression symp-
tomatology. The degree of synergistic effect we
observed was generally lower than that found by
Schmitz et al. (2007), particularly for the joint effect of
heart disease and depression. It seems probable that
this is, at least in part, a function of the differences
between the studies in terms of the methodological
features just mentioned.
There are a number of ways in which the co-
occurrence of mental and physical conditions could
have synergistic effects on disability. One of these
is through an underlying shared pathophysiology,
such as that associated with the functioning of
the autonomic nervous system [through the sym-
pathetic–adrenal–medullary (SAM) system] and the
neuroendocrine system [through the hypothalamic–
pituitary–adrenocortical (HPA) axis]. Disturbances
in both of these systems have been associated with
depression and anxiety disorders (Heim & Nemeroff,
1999 ; McEwen, 2003 ; Goodyer, 2007) and with a range
of physical disorders mediated by metabolic, cardio-
vascular and immune systems (McEwen, 1998 ;
Chrousos & Kino, 2007 ; Cohen et al. 2007). Allostatic
load refers to the cumulative biological wear and tear
that occurs through sustained output of glucocorti-
coids and catecholamines associated with chronic
or repeated malfunction of the HPA and SAM axes
(McEwen, 1998, 2003, 2007). Karlamanagla et al. (2002)
found that a summary measure of allostatic load pre-
dicted functional decline independently of individual
physiological markers, lifestyle and demographic
variables, and baseline levels of functioning. Allostatic
load may therefore be one mechanism through which
the combined effect of different morbidities on func-
tioning may be greater than the sum of the individual
effects.
A second possible mechanism is through the fre-
quently observed bi-directionality of relationship
between co-morbid mental and physical disorders
(Cohen & Rodriguez, 1995 ; Dew, 1998; Kiecolt-Glaser
et al. 2002). Bi-directionality may operate to compound
both mental and physical components of the co-
morbidity. Depression, for example, may facilitate the
development of diabetes through the metabolic effects
of overexposure to glucocorticoids as outlined above,
but then the resulting disability and lifestyle changes
required by the advent of diabetes can maintain or
exacerbate the depression. Hence, a self-perpetuating
feedback loop between mental and physical disorders
can develop; their co-morbidity then operates to in-
crease the morbidity of each disorder, and so too the
associated disability.
Other mechanisms for a synergistic effect of mental–
physical co-morbidity on disability include the possi-
bility that depression may exacerbate the disabling
effect of a chronic physical condition through its in-
fluence on treatment adherence and health behaviours
(Cohen & Rodriguez, 1995 ; Ciechanowski et al. 2000;
Evans et al. 2005). Depression can also interfere with
the psychological capacity to adjust to physical con-
ditions (Sharpe & Curran, 2006) and can affect the
perception and appraisal of pain, and the ability to
cope with it (Campbell et al. 2003 ; Van Puymbroeck
et al. 2007). Finally, it is possible that mental co-
morbidity is a marker of physical condition severity,
and it is the severity of the condition that increases
the associated disability relative to those physical con-
ditions occurring in the absence of mental disorder
(Stein et al. 2006).
This topic has important clinical ramifications.
Schettini Evans & Frank (2004) take the view that
if two conditions have additive effects on disability,
this indicates that both need to be targeted for treat-
ment to reduce their joint disability burden, and if
two conditions have synergistic effects, novel treat-
ments need to be designed and targeted to particular
co-morbidities. We are uncertain that the synergistic
effects of co-morbid disorders means that novel treat-
ments have to be designed, but we do consider that
these and other similar results present a strong case
for the need to treat both conditions. Although this
may seem a common-sense conclusion, it is apparently
not always the one adopted by clinicians when
confronted with mental–physical co-morbidity. For
example, some physicians in medical settings take
the view that mental disorder is an understandable
consequence of physical disease that does not require
a specific treatment focus (Evans et al. 2005). Similarly,
some mental health clinicians consider that ‘ living
with a mental illness is generally such a struggle that
physical health is of lesser importance’ (Hyland et al.
2003).
These findings need to be interpreted within the
context of the study limitations. First, the cross-
sectional nature of the surveys means that it cannot
be assumed that the disability measured here is a
consequence of either the mental or the physical
conditions reported. A second limitation is that the
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physical conditions were ascertained by a standard
check-list, rather than a physician’s examination,
which contrasts with the detailed assessment of
mental disorders. One of the effects of this limited
assessment is that we have no information on severity,
which means we cannot draw conclusions about
its contribution to the finding of synergy. While
acknowledging the limitation of self-report, methods
research indicates that self-report of diagnosis gener-
ally shows good agreement with medical records
data (Kehoe et al. 1994 ; NCHS, 1994; Kriegsman et al.
1996), and the presence of depressive or anxiety
symptoms has not been found to bias or inflate the
self-report of diagnosed physical conditions (Kolk
et al. 2002).
A third limitation is that the analyses of each
physical condition did not control for co-morbidity
with other physical conditions. Additionally, mental
disorders not included in the depression-anxiety
spectrum were not controlled for in the analyses. This
may mean that the distinctions between the groups
are less clear-cut than their labelling implies, but it
seems unlikely to have affected the pattern of results.
Fourth, the cutpoint for defining disability (on or
above the 90th percentile of the WMH WHODAS for
each country) may not mean the same thing in differ-
ent countries. The proportion of each country with any
disability on the WMH WHODAS showed consider-
able cross-national variation (Von Korff et al. in press),
so it is possible that the nature of the disability ex-
perienced by the 10% most disabled in a given popu-
lation would also vary. Other results from the WMH
surveys show marked cross-national differences in
prevalences of mental disorders (Demyttenaere et al.
2004), and it is not currently possible to disentangle
differences in prevalence from reporting differences
as a function of differing conceptualizations of mental
disorder. Despite these limitations to cross-national
comparisons, in the present study there was a general
tendency for those with both conditions to be more
likely to be severely disabled relative to either con-
dition alone ; a pattern that occurred in the majority of
countries. Moreover, the heterogeneity analyses did
not indicate significant variability in pooled estimates
across countries.
In conclusion, this first cross-national study of
the joint effect of mental and physical conditions on
the probability of severe disability adds to a growing
body of studies in finding that co-morbidity exerts
modest synergistic effects, such that the combined
disabling effect of mental and physical conditions
is somewhat greater than the summed effects of the
individual conditions. There are a number of mech-
anisms, biological, behavioural and psychological,
that could account for these results. Clinicians need
to rise to the challenge of according both mental and
physical conditions equal priority, in order for co-
morbidity to be adequately managed and disability
reduced.
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